Respiratory virus infections in cystic fibrosis

Paediatric Respiratory Reviews

Volumn 4, Issue 3, 2003, Pages 172-177

  Wat, Dennis ^a   Doull, Iolo ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Cystic fibrosis; Exacerbation; Virus

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE; OSELTAMIVIR; PALIVIZUMAB; SIALIDASE INHIBITOR; VIRUS DNA; VIRUS RNA; ZANAMIVIR;

ADENOVIRUS; ADOLESCENT; ADULT; BACTERIAL INFECTION; CHILD; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; GENE AMPLIFICATION; HOSPITALIZATION; HUMAN; IMMUNOFLUORESCENCE TEST; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INFLUENZA VIRUS C; LENGTH OF STAY; MICROSCOPY; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; PARAINFLUENZA VIRUS; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; ROTAVIRUS; SCORING SYSTEM; SEROLOGY; VIRUS CULTURE; VIRUS DETECTION; VIRUS INFECTION; VIRUS ISOLATION;

EID: 0042024971     PISSN: 15260550     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(03)00059-9     Document Type: Review

References (45)

1. Dodge JA, Morison S, Lewis PA et al. Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. Arch Dis Child 1997; 77: 493-496.
2. Riordan JR, Rommens JM, Kerem B et al. Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA. Science 1989; 245: 1066-1073.
3. Barasch J, al-Awqati Q. Defective acidification of the biosynthetic pathway in cystic fibrosis. J Cell Sci 1993; 17(Suppl.): 229-233.
4. Wood RE, Boat TF, Doershuk CF. Cystic fibrosis: State of the art. Am Rev Respir Dis 1976; 113: 833-877.
5. Beaudry PH, Marks MI, McDougall D, Desmond K, Rangel R. Is anti-Pseudomonas therapy warranted in acute respiratory exacerbation in children with cystic fibrosis? J Pediatr 1980; 97: 144-147.
6. Mearns M B. Natural history of pulmonary infection in cystic fibrosis. In: Sturgess JM (ed). Perspectives in Cystic Fibrosis. Toronto: Canadian Cystic Fibrosis Foundation; pp. 325-335, 1980.
7. Abman SH, Ogle JW, Harbeck RJ, Butler-Simon N, Hammond KB, Accurso FJ. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr 1991; 119: 211-217.
8. Smith AL, Ramsey B, Redding G, Hass J. Endobronchial infection in cystic fibrosis. Acta Pediatr Scand 1989; 363(Suppl.): 31-36.
9. Marks MI. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr 1981; 98: 173-179.
10. Pennington JE, Wolff SM, Puziss M. Summaries of a workshop on infections in patients with cystic fibrosis. J Infect Dis 1979; 140: 252-256.
11. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbation of asthma in 9-11 year old children. BMJ 1995; 310: 1225-1228.
12. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307: 982-986.
13. Ramsey BM, Gore EJ, Smith AL, Cooney MK, Redding GJ, Foy H. The effects of respiratory viral infections in patients with cystic fibrosis. Am J Dis Child 1989; 143: 662-668.
14. Smyth AR, Smyth RL, Tong CYW, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovinus on clinical status in cystic fibrosis. Arch Dis Child 1995; 73: 117-120.
15. Petersen NT, Hoiby N, Mordhorst CH, Lind K, Flensborg W, Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma: possible synergism with Pseudomonas aeruginosa. Acta Pediat Scand 1981; 70: 623-628.
16. Conway SP, Simmond EJ, Littlewood JM. Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax 1992; 47: 112-114.
17. Armstrong D, Grimwood K, Carlin JB. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol 1998; 26: 371-379.
18. Pribble CG, Black PG, Bosso JA, Turner RB. Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatr 1990; 117: 200-204.
19. Collinson J, Nicholson KG, Cancio E et al. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax 1996; 51: 1115-1122.
20. van den Hoogen BG, de Jong JC, Goren J et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001; 7: 719-724.
21. Bayer K M, Cherry J D. Nonbacterial pneumonia. In: Feigin R D, Cherry J D (eds). Textbook of Pediatric Infectious Diseases 2nd edn, Vol 1. Philadelphia: WB Saunders, 1987, pp. 288-300.
22. Parrott RH, Kim HW, Brandt CD, Chanock RM. Respiratory syncytial virus in infants and children. Prev Med 1974; 3: 473-480.
23. Hall C B. Parainfluenza viruses. In: Feigin R P, Cherry J D (eds). Textbook of Pediatric Infectious Diseases 2nd edn, Vol 2. Philadelphia: WB Saunders, 1987; pp. 1632-1645.
24. Zahvadnik J M, Cherry J D. Influenza viruses: In: Feigin R P, Cherry J D (eds). Textbook of Pediatric Infectious Diseases 2nd edn, Vol 2. Philadelphia: WB Saunders, 1987; 1709-1728.
25. Stockton J, Stephenson I, Fleming D, Zambon M. Human metapneumovirus as a cause of community-acquired respiratory illness. Emerg Infect Dis 2002; 8: 891-897.
26. Ong EL, Ellis ME, Webb AK et al. Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms. Thorax 1989; 44: 739-742.
27. Wang EE, Prober CG, Manson B, Corey E, Levison M. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl Med 1984; 311: 1653-1658.
28. Stroobant J. Viral infections in cystic fibrosis. I R Soc Med 1986; 76(Suppl. 12): 19-22.
29. Freymuth F, Vabret A, Galateau-Selle F et al. Detection of respiratory syncytial virus, parainfluenza virus, adenovirus and rhinovirus sequences in respiratory tract of infants by polymerase chain reaction and hybridisation. Clin Diagn Virol 1997; 8: 31-40.
30. Hiatt PW, Grace SC, Kozinetz CA et al. Effects of viral lower respiratory tract infections on lung function in infants with cystic fibrosis. Pediatrics 1999; 103: 619-626.
31. Johansen HK, Hoiby N. Seasonal onset of initial colonisation and chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis in Denmark. Thorax 1992; 47: 107-111.
32. Lloyd-Still JD, Khaw KT, Shwachman H. Severe respiratory disease in infants with cystic fibrosis. Pediatrics 1974; 53: 678-682.
33. Garland JS, Chan YM, Kelly KJ, Rice TB. Outcome of infants with cystic fibrosis requiring mechanical ventilation for respiratory failure. Chest 1989; 96: 136-138.
34. Walsh JJ, Dietlein LF, Now FN, Burch GE, Mogabgab WJ. Bronchotracheal response in human influenza. Arch Int Med 1961; 108: 98-110.
35. Winter B, Gwaltney JM, Hendley JO. Respiratory virus infection of monolayer cultures of human nasal epithelial cells. Am Rev Respir Dis 1990; 141: 839-845.
36. Ohrui T, Yamaya M, Sekizawa K et al. Effects of rhinovirus infection on hydrogen peroxide-induced alterations of barrier function in the cultured human tracheal epithelium. Am J Respir Crit Care Med 1998; 158: 241-248.
37. Fainstern V, Musher DM, Cate TR. Bacterial adherences to pharyngeal cells during viral infection. J Infect Dis 1980; 141: 172-176.
38. Mastronard JG, Monick MM, Hunninghake GW. Oxidant tone regulates IL-8 production in epithelium infected with respiratory syncitial virus. J Respir Cell Mol Biol 1995; 13: 237-244.
39. Ochiai H, Ikesue A, Kurokawa M, Nakajima K, Nakagawa H. Inhanced production of rat interleukin 8 by invitro and invivo infections with influenza A NWS virus. J Virol 1993; 67: 6811-6814.
40. Abu-Harb M, Bell F, Finn A et al. IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis. Eur Respir J 1999; 14: 139-143.
41. Everard ML, Swarbrick A, Wrightham M et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus-infection. Arch Dis Child 1994; 71: 428-432.
42. Teran LL, Johnson SL, Schroder J-M, Church MK, Holgate ST. Role of nasal Interleukin 8 in neutrophil recruitment and activation in children with virus induced asthma. Am J Respir Crit Care Med 1997; 155: 1362-1366.
43. Tan A, Bhalla P, Smyth R. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database Syst Rev 2000; 2: CD001753.
44. The Impact RSV Study Group. Palivizumab, a humanised respiratory syncytial virus monoclonal antibody reduces hospitalisation from respiratory syncytial virus infection in high risk infants. Pediatrics 1998; 102: 531-537.
45. Przyklenk B, Bauernfiend A, Bertele RM et al. Viral infections in the respiratory tract in patients with cystic fibrosis. Serodiagn Immunother Infect Dis 1988: 2: 217-225.